Begoña Pérez Moneo-rekin lankidetzan egindako argitalpenak (6)

2024

  1. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

    Biomedicine and Pharmacotherapy, Vol. 173

  2. Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP

    European Journal of Pediatrics

2023

  1. Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. “Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”

    Human Immunology, Vol. 84, Núm. 4, pp. 290-295

2014

  1. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry

    Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769

2013

  1. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): The SPIRIT registry

    Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 73-80